twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2012
vol. 114
 
Share:
Share:
abstract:
Original paper

Proton beam radiotherapy of uveal melanoma – preliminary results

Bożena Romanowska-Dixon
1
,
Arkadiusz Pogrzebielski
1
,
Anna Bogdali
1
,
Anna Markiewicz
1
,
Jan Swakoń
2
,
Paweł Olko
2
,
Marek Jeżabek
2
,
Beata Sas-Korczyńska
3
,
Elżbieta Pluta
3

  1. Klinika Okulistyki i Onkologii Okulistycznej Katedry Okulistyki Uniwersytetu Jagiellońskiego Collegium Medicum w Krakowie
  2. Instytut Fizyki Jądrowej Polskiej Akademii Nauk im. H. Niewodniczańskiego w Krakowie
  3. Centrum Onkologii, Instytut im. M. Skłodowskiej-Curie, Oddział w Krakowie
Online publish date: 2012/10/12
View full text Get citation
 
Purpose
Presentation of the proton beam radiotherapy (PBR) as a method of treatment of the uveal melanoma patients in the Department of Ophthalmology and Ocular Oncology and Nuclear Physics Institute in Cracow, Poland and their preliminary results.

Material and methods
Nine patients with only choroidal melanoma were treated using PBR between January and April 2011. There were 4 women (44%) and 5 men (56%), a mean age 56 years (38–72). The mean tumor thickness using ultrasounds was 4,14 mm (1,4–9,6 mm).

Results
The mean follow-up was 6 months (5–7). The mean tumor thickness after PBR was 2,47 mm (0–9,3 mm). In 2 patients endoresection of irradiated tumor mass was performed with final flat scar. After exclusion of these patients from analysis, the mean thickness was 3,17 mm (1,5–9,3 mm). In 6 patients the visual function was stable.

Conclusions
The preliminary results show that PBR is highly precise method of uveal melanoma treatment achieving high rates of local control. This method necessitates a close co-operation between ophthalmologist, oncologist, radiotherapists, and medical physicist as well as an elaboration of own procedures of planning and treatment.

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.